AMGN vs VALU · P/E 24, rev $10.05B vs P/E 15, rev $33.4M
Amgen Inc (AMGN) versus Value Line Inc (VALU) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Value Line Inc (VALU) is a financial data & stock exchanges company listed on NASDAQ.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported VALU revenue for 2026-04-30 was $33.4M. Net income was $21.6M. Revenue was down 4.7% from 2025-04-30 to 2026-04-30. VALU currently screens at market cap $324.4M and trailing P/E 14.8.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. VALU currently screens at market cap $324.4M and trailing P/E 14.8.
Not investment advice. Open the AMGN and VALU stock pages for the full models.
Not investment advice.